**Figure 7.** **Relationship between the immune prognostic model (IPM) and other clinical information.** (**A**) Univariate and multivariate regression analyses of the relationship between the IPM and clinicopathological features regarding prognostic value. (**B**) Nomogram for predicting the probability of 1-, 3-, and 5-year overall survival (OS) in lung adenocarcinoma (LUAD) patients. (**C**) Calibration plot of the nomogram for predicting the probability of OS at 1, 3, and 5 years.